Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,850.39 +414.73 (+0.62%) CMC Crypto 200
1,367.10 -6.74 (-0.49%)
JNJ Jan 2025 90.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 11:35AM EDT
Loading interactive chart…
- Simply Wall St.
Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
The fact that multiple Johnson & Johnson ( NYSE:JNJ ) insiders offloaded a considerable amount of shares over the past...
- Reuters
J&J-backed startup Rapport files for US IPO
Rapport, which develops small molecule medicines for patients suffering from central nervous system disorders, is gearing up for a listing as the IPO market recovers from a slump amid increasing hopes of a soft landing for the economy. The company said it will be selling shares in the IPO, but did not disclose how many nor the price range. Rapport's net loss widened to $34.8 million in 2023 from $10.7 million a year earlier.
- Zacks
J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
Johnson & Johnson (JNJ) inks deal to acquire Proteologix, Inc. for $850 million in cash. The transaction is expected to be closed in mid-2024.
© 2024 Yahoo. All rights reserved.